Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Exploring the multiverse: the impact of researchers’ analytic decisions on relationships between depression and inflammatory markers
    Published on 2023-06-19
    2 years ago
  • Microglia depletion facilitates the display of maternal behavior and alters activation of the maternal brain network in nulliparous female rats
    Published on 2023-06-17
    2 years ago
  • Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
    Published on 2023-06-15
    2 years ago
  • The effect of ketamine on synaptic mistuning induced by impaired glutamate reuptake
    Published on 2023-06-10
    2 years ago
  • Publisher Correction to: Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques
    Published on 2023-06-07
    2 years ago
  • Altered regulation of oligodendrocytes associated with parvalbumin neurons in the ventral hippocampus underlies fear generalization in male mice
    Published on 2023-06-05
    2 years ago
  • Methylphenidate undermines or enhances divergent creativity depending on baseline dopamine synthesis capacity
    Published on 2023-06-03
    2 years ago
« Previous 1 … 77 78 79 80 81 … 143 Next »
Journal of Psychopharmacology
  • Responses to social evaluative stress in regular cannabis smokers
    Published on 2021-02-08
    4 years ago
  • Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders
    Published on 2021-02-06
    4 years ago
  • Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis
    Published on 2021-02-06
    4 years ago
  • Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
    Published on 2021-02-03
    4 years ago
  • Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
    Published on 2021-01-11
    4 years ago
  • Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis
    Published on 2021-01-09
    4 years ago
  • Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
    Published on 2021-01-09
    4 years ago
« Previous 1 … 77 78 79 80 81 … 124 Next »
European Neuropsychopharmacology
  • A proof-of-concept study of maternal immune activation mediated induction of Toll-like receptor (TLR) and inflammasome pathways leading to neuroprogressive changes and schizophrenia-like behaviours in offspring
    Published on 2021-07-11
    4 years ago
  • Adolescent animal models of addiction
    Published on 2021-07-06
    4 years ago
  • Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation
    Published on 2021-07-06
    4 years ago
  • Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study
    Published on 2021-07-06
    4 years ago
  • α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects
    Published on 2021-06-21
    4 years ago
  • Parkinson’s disease and REM sleep behavior disorder with special reference to cognitive decline
    Published on 2021-06-21
    4 years ago
  • Offspring studies: Predicting conversion to psychosis
    Published on 2021-06-20
    4 years ago
« Previous 1 … 77 78 79 80 81 … 144 Next »

   Pharma Pub